Skip to Main Content
Table 1

Participant characteristics

Type 1 diabetic subjectsNondiabetic subjects
n 458 546 
Age (years) 43.6 ± 8.9 47.0 ± 8.7 
Sex (men) 214 (46.7) 277 (50.8) 
Diabetes duration (years) 29.4 ± 8.7  
GHb (%) 7.9 ± 1.2 5.6 ± 0.5 
Race/ethnicity (% non-Hispanic white) 94.8 86.6 
BMI (kg/m226.8 ± 4.8 26.6 ± 4.8 
BDI-II score 7.4 ± 7.3 5.0 ± 5.4 
Antidepressant medication use (yes) 93 (20.7) 65 (12.1) 
Length of time on antidepressant medication (years) 3.65 ± 3.37 2.88 ± 3.08 
Complications (total) 209 (45.7)  
Retinopathy 166 (36.5)  
Blindness 27 (6.0)  
Neuropathy 97 (21.4)  
Amputation 6 (1.3)  
Transplantation 6 (1.3)  
Presence of CAC (yes) 249/419 (59.4) 233/493 (47.3) 
Square root of CAC volume 5.96 ± 9.27 3.26 ± 6.56 
Type 1 diabetic subjectsNondiabetic subjects
n 458 546 
Age (years) 43.6 ± 8.9 47.0 ± 8.7 
Sex (men) 214 (46.7) 277 (50.8) 
Diabetes duration (years) 29.4 ± 8.7  
GHb (%) 7.9 ± 1.2 5.6 ± 0.5 
Race/ethnicity (% non-Hispanic white) 94.8 86.6 
BMI (kg/m226.8 ± 4.8 26.6 ± 4.8 
BDI-II score 7.4 ± 7.3 5.0 ± 5.4 
Antidepressant medication use (yes) 93 (20.7) 65 (12.1) 
Length of time on antidepressant medication (years) 3.65 ± 3.37 2.88 ± 3.08 
Complications (total) 209 (45.7)  
Retinopathy 166 (36.5)  
Blindness 27 (6.0)  
Neuropathy 97 (21.4)  
Amputation 6 (1.3)  
Transplantation 6 (1.3)  
Presence of CAC (yes) 249/419 (59.4) 233/493 (47.3) 
Square root of CAC volume 5.96 ± 9.27 3.26 ± 6.56 

Data are means ± SD, n (%), or proportion in unadjusted analysis unless indicated otherwise.

Close Modal

or Create an Account

Close Modal
Close Modal